173 related articles for article (PubMed ID: 31115582)
1. Cytokeratin 18 regulates the transcription and alternative splicing of apoptotic‑related genes and pathways in HeLa cells.
Cheng Y; Qin K; Huang N; Zhou Z; Xiong H; Zhao J; Zhang Y; Yu S
Oncol Rep; 2019 Jul; 42(1):301-312. PubMed ID: 31115582
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 18 expression inhibits cytokine-induced death of cervical cancer cells.
Sullivan BT; Cherry JA; Sakamoto H; Henkes LE; Townson DH; Rueda BR
Int J Gynecol Cancer; 2010 Dec; 20(9):1474-81. PubMed ID: 21119362
[TBL] [Abstract][Full Text] [Related]
3. Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
Ma HR; Cao L; Wang F; Cheng C; Jiang R; Zhou H; Xie Z; Wuermanbieke S; Qian Z
Oncol Rep; 2020 May; 43(5):1536-1546. PubMed ID: 32323860
[TBL] [Abstract][Full Text] [Related]
4. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 18 knockdown decreases cell migration and increases chemosensitivity in non-small cell lung cancer.
Zhang B; Wang J; Liu W; Yin Y; Qian D; Zhang H; Shi B; Li C; Zhu J; Zhang L; Gao L; Wang C
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2479-2487. PubMed ID: 27601168
[TBL] [Abstract][Full Text] [Related]
7. Expression and distribution of cytokeratin 8/18 intermediate filaments in bovine antral follicles and corpus luteum: an intrinsic mechanism of resistance to apoptosis?
Townson DH; Putnam AN; Sullivan BT; Guo L; Irving-Rodgers HF
Histol Histopathol; 2010 Jul; 25(7):889-900. PubMed ID: 20503177
[TBL] [Abstract][Full Text] [Related]
8. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
9. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
11. DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
Qin K; Jian D; Xue Y; Cheng Y; Zhang P; Wei Y; Zhang J; Xiong H; Zhang Y; Yuan X
Oncol Rep; 2021 Mar; 45(3):1213-1225. PubMed ID: 33650667
[TBL] [Abstract][Full Text] [Related]
12. A potential association between Helicobacter pylori CagA EPIYA and multimerization motifs with cytokeratin 18 cleavage rate during early apoptosis.
Saberi S; Douraghi M; Azadmanesh K; Shokrgozar MA; Zeraati H; Hosseini ME; Mohagheghi MA; Parsaeian M; Mohammadi M
Helicobacter; 2012 Oct; 17(5):350-7. PubMed ID: 22967118
[TBL] [Abstract][Full Text] [Related]
13. QKI-Regulated Alternative Splicing Events in Cervical Cancer: Pivotal Mechanism and Potential Therapeutic Strategy.
Luo Y; Li Y; Ge P; Zhang K; Liu H; Jiang N
DNA Cell Biol; 2021 Oct; 40(10):1261-1277. PubMed ID: 34551268
[TBL] [Abstract][Full Text] [Related]
14. Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: a prospective study.
Simopoulos C; Tsaroucha AK; Asimakopoulos B; Giatromanolaki A; Gavriilidis P; Polychronidis A; Karayiannakis A
BMC Gastroenterol; 2008 May; 8():14. PubMed ID: 18460214
[TBL] [Abstract][Full Text] [Related]
15. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
Huang N; Wei Y; Cheng Y; Wang X; Wang Q; Chen D; Li W
Genes Genomics; 2022 Jun; 44(6):637-650. PubMed ID: 35066810
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 18 is a specific marker of bovine intestinal M cell.
Hondo T; Kanaya T; Takakura I; Watanabe H; Takahashi Y; Nagasawa Y; Terada S; Ohwada S; Watanabe K; Kitazawa H; Rose MT; Yamaguchi T; Aso H
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G442-53. PubMed ID: 21193527
[TBL] [Abstract][Full Text] [Related]
17. Cx32 suppresses extrinsic apoptosis in human cervical cancer cells via the NF‑κB signalling pathway.
Lai Y; Fan L; Zhao Y; Ge H; Feng X; Wang Q; Zhang X; Peng Y; Wang X; Tao L
Int J Oncol; 2017 Oct; 51(4):1159-1168. PubMed ID: 28902345
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
19. hnRNPDL extensively regulates transcription and alternative splicing.
Li RZ; Hou J; Wei Y; Luo X; Ye Y; Zhang Y
Gene; 2019 Mar; 687():125-134. PubMed ID: 30447347
[TBL] [Abstract][Full Text] [Related]
20. Effects of MACC1 siRNA on biological behaviors of HeLa.
Chai H; Yang Y
Arch Gynecol Obstet; 2014 Jun; 289(6):1271-80. PubMed ID: 24346124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
